FindTrial
Sign In

Homoeopathic treatment of cancer pain

Efficacy of individualized homeopathic medicines in LM potencies in addition to standard anticancer care in cancer pain management in adults A series of n of 1 trials using Synthesis Repertory - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077959
Enrollment
21
Registered
2024-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G893- Neoplasm related pain (acute) (chronic)

Interventions

Intervention1: Individualized Homoeopathic medicines and standard care: Individualized homeopathic medication (IHM) following the method of the sixth edition of the Organon is summarized as below: In
7 doses to be marked on the vial
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from pain in cancer-related pain (ICD-10 codeG89.3) for at least 3 months. 2. Patients who screen positively for pain (values of 5-6 out of 10 indicating moderate pain). 3. Aged between 18 to 75 yrs 4. Either sex or transgenders. 5. Patients ability to understand Bengali or English or Hindi.

Exclusion criteria

Exclusion criteria: 1. Patient has NPRS score greater than equal to 7 (severe pain) 2. Patients not willing to cooperate and not giving informed consent to participate in the trial. 3. Cases too sick for consultation. 4. Cases willing for or requiring immediate surgical intervention or undergoing major surgery in last 6 months 5. Diagnosed cases of uncontrolled systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 6. Patient with psychiatric disorders 7. Undergoing homoeopathic treatment for chronic disease within last 6 months Substance abuse and/or dependence. 8. Pregnant, in puerperium and lactating women 9. Simultaneous participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
SF-MPQ score (Short form McGill Pain Questionnaire)Timepoint: Baseline, every 10 days, up to 2 months—

Secondary

MeasureTime frame
EORTC QLQ-C15-PAL (European organization for research and treatment of cancer quality of life questionnaire core 15 palliative care)Timepoint: Baseline, every 10 days, up to 2 months;PHQ-9 (Patient Health Questionnaire)Timepoint: Baseline, every 10 days, up to 2 months—

Countries

India

Contacts

Public ContactShubhamoy Ghosh

D N De Homoeopathic Medical College and Hospital

shubhamoy67@gmail.com9804151933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026